Go to Discovery / Non-clinical section >>
Go to Clinical Development section >>
Go to Authorization / Approval section >>
Go to Post-approval / Maintenance section >>
Go to Program Management section >>
Please DO NOT send us event/conference information. We will not respond and these will be deleted immediately.
Where are you located?AfghanistanAlbaniaAlgeriaArmeniaArgentinaAustriaAustraliaAzerbaijanBangladeshBelarusBelgiumBosnia and HerzegovinaBoliviaBrazilBritish Virgin IslandsBulgariaCanadaChileChinaColombiaCosta RicaCroatiaCubaCyprusCzech RepublicDenmarkDominican RepublicEcuadorEl SalvadorEstoniaEgyptSpainFinlandFranceGeorgiaGermanyGhanaGreeceHondurasHungaryIcelandIndiaIndonesiaIsraelIrelandIraqIran, Islamic Republic ofIsle of ManItalyJamaicaJapanJordanKazakhstanKorea (North)Korea (South)KuwaitLatviaLebanonLiechtensteinLithuaniaLuxemburgMacaoMacedonia, Republic ofMaltaMalaysiaMarshall IslandsMexicoMoroccoMonacoMoldovaMontenegroMyanmarNamibiaNetherlandsNew ZealandNorwayOmanPakistanPalestinian TerritoryPanamaParaguayPeruPhilippinesPolandPortugalPuerto RicoQatarRomaniaSerbiaRussian FederationSaudi ArabiaSingaporeSloveniaSlovakiaSouth AfricaSri LankaSudanSwedenSwitzerlandSyrian Arab Republic (Syria)Taiwan, Republic of ChinaThailandTunisiaTurkeyUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayVenezuela (Bolivarian Republic)Vietnam
Select your state:
---AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Please tick this box if you agree to periodic updates from PharmaLex. You can unsubscribe at any time at email@example.com
Please leave this field empty.
We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for
This can be specific information about signing up to the newsletter.
Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.
Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.
In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email firstname.lastname@example.org or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.